Inventories

3 Months Ended

Mar. 31, 2022

Inventory Disclosure [Abstract]

Inventories

(5)       Inventories

At March 31, 2022 and December 31, 2021, the company held inventories of $889,155 and $924,775 respectfully.

Inventories consisted of work in process for the following business segments:

	March 31, 2022		December 31, 2021
Radiochemical Products	$	67,782	$	79,747
Cobalt Products		416,642		441,749
Nuclear Medicine Products		404,731		403,279
		889,155		924,775

The Company has contracted with several customers for the sale of some of this cobalt product material and has collected advance payments for project management, up-front handling, and other production costs from those customers. The advance payments from customers were recorded as unearned revenue which are recognized in the Company’s condensed consolidated financial statements as cobalt products are completed and shipped. For the three months ended March 31, 2022 and 2021, the Company recognized approximately $10,600 and $7,800, respectively, of revenue in its condensed consolidated statements of operations for customer orders filled during the period under these cobalt contracts.